Document is current

Article History

Received: 10 March 2025

Accepted: 23 April 2025

First Online: 13 May 2025

Declarations

:

: Maria Esposito: Has served as a speaker/consultant for Abbvie, Amgen, Almirall, Eli Lilly, Janssen, Leo Pharma, Novartis, Pfizer, Sanofi, uCB. Maria Concetta Fargnoli: Has served as a consultant/advisor, received speaker honoraria and/or grants, and/or participated as an investigator for Amgen, Almirall, Abbvie, Boehringer Ingelheim, BMS, Galderma, Kyowa Kyrin, Incyte, Leo Pharma, Pierre Fabre, uCB, Lilly, Pfizer, Janssen, MSD, Novartis, Sanofi, Regeneron, Sun Pharma, Takeda. Matteo Megna: Has acted as a speaker or consultant for Abbvie, Amgen, Almirall, Eli Lilly, Novartis, Janssen, uCB, Leo Pharma. Anna Balato: Has acted as a speaker and/or consultant for Abbvie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Meyer-Squibb, Janssen, Eli Lilly, Leo Pharma, Novartis, Sanofi, uCB. Martina Burlando: Has acted as a speaker or consultant for Abbvie, Eli Lilly, Janssen, Leo Pharma, uCB, Novartis, Bristol-Meyer-Squibb, and Boehringer Ingelheim. Emanuele Cozzani: Has acted as a speaker or consultant for Abbvie, Almirall, Eli Lilly, Leo Pharma, Novartis. Paolo Gisondi: Has acted as a speaker or consultant for Abbvie, Amgen, Almirall, Eli Lilly, Janssen, Leo Pharma, uCB, Novartis, Sanofi, Pierre Fabre. Paolo Gisondi is Editorial Board members of Dermatology and Therapy. Paolo Gisondi were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Anna Campanati: Has served as a speaker, consultant, or advisory board member for Abbvie, Almirall, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Galderma, Incyte, Leo Pharma, Merck Sharp & Dohme, Janssen-Cilag, Novartis, Pfizer, Regeneron, Sanofi-Aventis, and UCB Pharma. Anna Campanati is Editorial Board members of Dermatology and Therapy. Anna Campanati is not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Diego Orsini: Has acted as a speaker and/or consultant for Abbvie, Leo Pharma, UCB, Bristol-Meyer-Squibb, and Boehringer Ingelheim. Annunziata Dattola: Has acted as a speaker, consultant, or advisory board member for Abbvie, Almirall, Amgen, Eli Lilly, Leo Pharma, Janssen, Novartis, Boehringer Ingelheim, and uCB Pharma. Giacomo Caldarola: Has received honoraria as a speaker and consultant for Abbvie, Almirall, Biogen, Eli Lilly, Leo Pharma, Novartis, Janssen, Sanofi, Pfizer, and UCB Pharma. Clara De Simone: Has received honoraria as a speaker or advisory board member or participated in clinical trials for AbbVie, Almirall, Amgen, Leo Pharma, Eli Lilly, Janssen, Novartis, Pfizer, Sanofi Genzyme, and uCB Pharma. Elena Campione: Has served as an advisory board member, received speaker fees, and/or research grants from Almirall, Amgen, Abbvie, Bristol Myers Squibb, Incyte, Leo Pharma, and uCB. Antonio Costanzo: Has acted as a consultant and/or speaker for AbbVie, Almirall, Amgen, Janssen, Leo Pharma, Eli Lilly, Galderma, Boehringer, Novartis, Pfizer, Sandoz, and uCB. Alessandra Narcisi: Has served on advisory boards, received speaker honoraria, and research grants from Almirall, AbbVie, BMS, Leo Pharma, Celgene, Eli Lilly, Janssen, Novartis, Sanofi-Genzyme, Amgen, and Boehringer Ingelheim. Piergiorgio Malagoli: Has acted as a speaker for AbbVie, Lilly, Novartis, Janssen-Cilag, Celgene, Leo Pharma, and Almirall. Paolo Dapavo: Has acted as a speaker for Novartis, AbbVie, Sanofi, uCB, Janssen, Lilly, and Leo Pharma. Francesco Loconsole: Has served on advisory boards and/or received honoraria for lectures from AbbVie, Janssen-Cilag, Novartis, Lilly, and Sanofi. Marina Venturini: Has served as an advisory board member and/or consultant, received speaker fees, and/or participated in clinical trials for AbbVie, Almirall, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly, Galderma, Janssen, Leo Pharma, Novartis, and uCB Pharma. Andrea Carugno: Has acted as a speaker and/or consultant for Almirall, Amgen, Abbvie, Boehringer Ingelheim, Eli Lilly, Leo Pharma, Janssen-Cilag, Novartis, and uCB Pharma. All other authors have no conflicts of interest to declare.

: This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. The ethics committee of UNIVPM approved the study protocol and all enrolled participants provided written informed consent. The patients in this manuscript have given written informed consent to publication of their case details. The study was approved by local ethical committees of each center (see supplementary material).